Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Jan 13;17(1):5. doi: 10.1186/s13058-014-0512-9

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Blanchard et al.; licensee BioMed Central. 2015

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

BRCA1-IRIS overexpression promotes EMT and invasion in HME cells, while inactivation suppresses them in TNBC cells. (A) Representative images showing the invasion ability of MDA-MB-231 (A and H) and MDA-MB-468 (D and K) cells through matrigel-coated Boyden chambers and the significant retardation of this invasion ability following BRCA1-IRIS silencing in MDA-MB-231 (B and I) and MDA-MB-468 (E and L) or BRCA1-IRIS inactivation using IRIS peptide in MDA-MB-231 (C and J) and MDA-MB-468 (F and M) cells on day 7. Scale bars in A-F and H-M = 1,000 μm. Quantitative analysis of invasive ability of the indicated cells shown as cells travelled to the other side of the transwells (G) or jumped to the lower well of the Boyden chamber (N). (O) The expression of the indicated EMT biomarkers in HME or BRCA1-IRIS overexpressing HME cells as well as MDA-MB-231 or MDA-MB-468 cells expressing or silenced from BRCA1-IRIS. Please note that BRCA1-IRIS and H2B blots used are the same as those used in Figure 4G. The expression of the indicated EMT/invasion biomarkers in HME (P1, Q1, R1, and S1), BRCA1-IRIS-overexpressing HME (P2, Q2, R2 and S2), MDA-MB-468 (P3, Q3, R3 and S3) or MDA-MB-468 silenced from BRCA1-IRIS (P4, Q4, R4 and S4) cells. Scale bars in P1-P4 and S1-S4 = 20 μm, and in Q1-Q4 and R1-R4 = 50 μm. EMT, epithelial to mesenchymal transition; HME, human mammary epithelial cells; TNBC, triple negative breast cancer.